rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Conexeu Sciences Inc.

CNXU · Nasdaq

Health CareMedical Devices

We hold no 150-day reading for CNXU yet: it needs about 200 sessions of history. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 27% (−6 points in four weeks).

Statistics

Last close, 23 Oct 2026
3.1 −6.06%
52-week range
—
Volume
0.17M
Average volume (50 days)
—
Relative volume
—
Rotation
not in the set
Weeks in an uptrend
—
Industry in uptrend
29% -4 in 4 wk
Insider buys, 12 months
$2.2M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
9

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

24 Apr – 23 Oct
19%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Price and volume

$2.96$3.99$5.0211 Sep23 Sep5 Oct14 Oct23 Oct
close

Daily bars to 23 Oct 2026: 30 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$1.3MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Lynn Sebastian PurcellDirector, 10% ownerbought166,666at $3.0015 Oct 2026filed 19 Oct 2026
Lynn Sebastian PurcellDirector, 10% ownerbought166,666at $0.0015 Oct 2026filed 19 Oct 2026
Lynn Sebastian PurcellDirector, 10% ownerbought202,500at $0.8018 Jun 2026filed 23 Jun 2026
Lynn Sebastian PurcellDirector, 10% ownerbought202,500at $0.00118 Jun 2026filed 23 Jun 2026
Onepointtwo Capital Ventures Llc10% ownerbought422,500at $0.8012 May 2026filed 14 May 2026
Onepointtwo Capital Ventures Llc10% ownersold422,500at $0.00112 May 2026filed 14 May 2026
Onepointtwo Capital Ventures Llc10% ownerbought422,500at $0.00112 May 2026filed 14 May 2026
Lynn Sebastian PurcellDirector, 10% ownerbought422,500at $0.8012 May 2026filed 14 May 2026
Lynn Sebastian PurcellDirector, 10% ownersold422,500at $0.00112 May 2026filed 14 May 2026
Lynn Sebastian PurcellDirector, 10% ownerbought422,500at $0.00112 May 2026filed 14 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders9
New · exited9 · 0
Reported value$287K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
UBS Group AGnew · filed 13 Aug 202612,264$134K+12,264
MORGAN STANLEYnew · filed 13 Aug 20265,871$64K+5,871
CITIGROUP INCnew · filed 3 Aug 20265,219$57K+5,219
HOLLENCREST CAPITAL MANAGEMENTnew · filed 13 Aug 20261,000$11K+1,000
ROYAL BANK OF CANADAnew · filed 14 Aug 2026887$10K+887
MERCER GLOBAL ADVISORS INCnew · filed 11 Aug 2026425$4,641+425
Integrated Wealth Concepts LLCnew · filed 12 Aug 2026400$4,368+400
JONES FINANCIAL COMPANIES LLLPnew · filed 14 Aug 2026100$1,096+100
OSAIC HOLDINGS, INC.new · filed 14 Aug 2026100$1,092+100

Everyone who traded it

Lynn Sebastian Purcell Company insiderDirector, 10% owner · last 15 Oct 20263 · 0
David Robert Bogart Company insiderChief Commercial Officer · last 25 Sep 20260 · 0
Jeffrey Nathan Sharpe Company insiderDirector · last 14 Sep 20260 · 0
Michael G. Wright Company insider10% owner · last 18 Jun 20260 · 0
Zbigniew Paul Lorenc Company insiderDirector · last 14 May 20260 · 0
OnePointTwo Capital Ventures LLC Company insider10% owner · last 12 May 20261 · 0

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

No ratio computed from its SEC filings yet.

Analyst forecasts

No analyst forecasts yet.